Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age65+
SponsorCentre Francois Baclesse

About this trial

The aim of this study was to evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Men or women aged 65 or over

Candidate for scheduled major oncological surgery and/or surgery with high morbidity

Patient able to walk for 10 minutes on the walking platform at the time of the test

Patient affiliated to a social security system

Disqualifiers

Patient with severe undernutrition (BMI<18, and/or weight loss >15% in 6 months or >10% in 1 month)

Emergency surgery

Physical contraindications preventing use of the platform

Simultaneous participation in another clinical study that could compromise the conduct of this study

Trial design

Design model

Single group

Treatments tested in this trial

  • Early rehabilitation through Adapted Physical Activity

    Device

    From the day after surgery, 1 to 2 walking sessions with walking platform, lasting 6 to 30 minutes (min-max), will be proposed daily until the day of discharge.

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Adapted physical activityExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

To evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.

Proportion of patients having recovered their preoperative walking speed at hospital discharge

Time frame
at hospital discharge (approximately 15 to 30 days after surgery)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.